NTRB logo

Nutriband (NTRB) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

01 October 2021

Indexes:

Not included

Website:

http://www.nutriband.com

Description:

Nutriband (NTRB) is a biotechnology company focused on developing innovative transdermal drug delivery systems. Their products aim to improve the effectiveness and convenience of medications, enhancing patient compliance and overall health outcomes. Nutriband combines advanced technology with a commitment to better healthcare solutions.

Key Details

Price

$4.77

Market Cap

$52.93 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$2.09 M(+0.27% YoY)

Annual EPS

-$0.69(-30.19% YoY)

PE Ratio

-

Annual ROE

-73.08%

Annual Debt To Equity

0.03

Beta

0.61

Events Calendar

Earnings

Next earnings date:

Dec 13, 2024

Recent quarterly earnings:

Sept 03, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 15, 2022

Analyst ratings

Recent major analysts updates

26 July '22 Small Cap Consumer Research
Buy

Screeners with NTRB included

Small cap stocks
NASDAQ earnings calendar
Stocks below SMA 200
Most recommended stocks
High Altman Z score stocks
Oversold stocks with upcoming earnings

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.77
NTRB price is $4.77

Price YTD Change

+104.72%
NTRB price is up +104.72% since January 1st

Price All-time High

$8.87
NTRB price is currently -46.22% below its historical high of $8.87

Market Cap

$52.93 M
NTRB market capitalization is $52.93 million

Beta

0.61
NTRB beta is 0.61

200-day SMA

$4.94
NTRB 200-day simple moving average is currently -3.49% below its 200-day simple moving average

14-day RSI

39.98
NTRB 14-day relative strength index is 39.98

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+120.97%
NTRB annual revenue is up +120.97% over the past 3 years

Annual Net Income 3-Year Change

-87.03%
NTRB annual net profit is down -87.03% over the past 3 years

Annual EPS 3-Year Change

-57.86%
NTRB annual earnings per share is down -57.86% over the past 3 years

Annual Gross Profit

$862.10 K
NTRB annual gross profit is $862.10 thousand

Annual Operating Profit

-$4.87 M
NTRB annual operaing income is -$4.87 million

Annual Operating Profit 3-Year Change

-87.68%
NTRB annual operaing income is down -87.68% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Gross Margin Sector Rank

36.65%
NTRB annual gross profit margin is higher than 36.65% of companies in Healthcare sector

Annual Operating Margin Sector Rank

33.61%
NTRB annual operating profit margin is higher than 33.61% of companies in Healthcare sector

Annual Net Margin Sector Rank

32.86%
NTRB annual net profit margin is higher than 32.86% of companies in Healthcare sector

Annual ROE

-73.08%
NTRB annual return on equity is -73.08%

Annual ROA

-64.63%
NTRB annual return on assets is -64.63%

Annual EBIT

-$5.41 M
NTRB annual earnings before interest & taxes is -$5.41 million

Annual EBITDA

-$5.12 M
NTRB annual earnings before interest, taxes, depreciation & amortization is -$5.12 million

Annual Interest Coverage Ratio

-71.37
NTRB annual interest coverage ratio is -71.37

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PB Ratio Sector Rank

74.85%
NTRB price to book ratio is higher than 74.85% of companies in Healthcare sector

PS Ratio Sector Rank

87.93%
NTRB price to sales ratio is higher than 87.93% of companies in Healthcare sector

Enterprise Value

$46.38 M
NTRB enterprise value is $46.38 million

Enterprise Value 1-Year Change

+108.04%
NTRB enterprise value is up +108.04% year-on-year

EV/EBITDA

-6.73
NTRB EV/EBITDA is -6.73

EV/EBITDA Sector Rank

19.77%
NTRB EV/EBITDA is higher than 19.77% of companies in Healthcare sector

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Debt To Equity Sector Rank

55.48%
NTRB annual debt to equity ratio is higher than 55.48% of companies in Healthcare sector

Annual Quick Ratio

0.85
NTRB annual quick ratio is 0.85

Annual Quick Ratio Sector Rank

16.52%
NTRB annual quick ratio is higher than 16.52% of companies in Healthcare sector

Annual Current Ratio

1.02
NTRB annual current ratio is 1.02

Annual Current Ratio Sector Rank

14.4%
NTRB annual current ratio is higher than 14.4% of companies in Healthcare sector

Annual Total Assets

$7.52 M
NTRB annual total assets is $7.52 million

Annual Current Assets

$1.02 M
NTRB annual total current assets is $1.02 million

Annual Total Liabilities

$1.08 M
NTRB annual total liabilities is $1.08 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-1087.31%
NTRB annual cash flow from operations is down -1087.31% over the past 3 years

Annual CFI 3-Year Change

-177.31%
NTRB annual cash flow from investing activities is down -177.31% over the past 3 years

Annual CFF 3-Year Change

+461.12%
NTRB annual cash flow from financing activities is up +461.12% over the past 3 years

Annual CAPEX

$51.80 K
NTRB annual capital expenditures is $51.80 thousand

Annual FCF

-$3.58 M
NTRB annual free cash flow is -$3.58 million

Annual FCF 3-Year Change

-1104.75%
NTRB annual free cash flow is down -1104.75% over the past 3 years

Institutional Ownership

Similar stocks

NXL logo
Nexalin Technology (NXL)
MAIA logo
MAIA Biotechnology (MAIA)
THTX logo
Theratechnologies (THTX)
DTIL logo
Precision BioSciences (DTIL)
KZR logo
Kezar Life Sciences (KZR)
ENZ logo
Enzo Biochem (ENZ)
STTK logo
Shattuck Labs (STTK)
173859 (BGM)
SCYX logo
SCYNEXIS (SCYX)
Nutriband Inc. Authorizes $1M Share Buyback Program
Nutriband Inc. Authorizes $1M Share Buyback Program
Nutriband Inc. Authorizes $1M Share Buyback Program
NTRB
accesswire.com16 September 2024

ORLANDO, FL / ACCESSWIRE / September 16, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of September 16, 2024, the Company had 11,106,185 shares of common stock outstanding.

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025
NTRB
accesswire.com04 September 2024

ORLANDO, FL / ACCESSWIRE / September 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second quarter ended July 31, 2024. The Company reported a strong cash position at quarter end, reinforcing its ability to advance the development of its lead product, AVERSA™ Fentanyl, with an NDA submission targeted for the first half of 2025.

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25
NTRB
accesswire.com19 July 2024

ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased to invite investors to a webinar on July 25, 2024, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Nutriband Chairman and President Serguei Melnik and Chief Executive Officer Gareth Sheridan, who will share insight into the Company's current operations and upcoming milestones.

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors
NTRB
accesswire.com16 May 2024

The Glinka family contributed $4.5 million to Nutriband during the Company's private placement in April 2024. Nutriband Inc. appointed Sergei Glinka to its board of directors, a well-respected business executive with extensive experience in leadership roles at prominent European companies.

FAQ

  • What is the primary business of Nutriband?
  • What is the ticker symbol for Nutriband?
  • Does Nutriband pay dividends?
  • What sector is Nutriband in?
  • What industry is Nutriband in?
  • What country is Nutriband based in?
  • When did Nutriband go public?
  • Is Nutriband in the S&P 500?
  • Is Nutriband in the NASDAQ 100?
  • Is Nutriband in the Dow Jones?
  • When was Nutriband's last earnings report?
  • When does Nutriband report earnings?
  • Should I buy Nutriband stock now?

What is the primary business of Nutriband?

Nutriband (NTRB) is a biotechnology company focused on developing innovative transdermal drug delivery systems. Their products aim to improve the effectiveness and convenience of medications, enhancing patient compliance and overall health outcomes. Nutriband combines advanced technology with a commitment to better healthcare solutions.

What is the ticker symbol for Nutriband?

The ticker symbol for Nutriband is NASDAQ:NTRB

Does Nutriband pay dividends?

No, Nutriband does not pay dividends

What sector is Nutriband in?

Nutriband is in the Healthcare sector

What industry is Nutriband in?

Nutriband is in the Biotechnology industry

What country is Nutriband based in?

Nutriband is headquartered in United States

When did Nutriband go public?

Nutriband's initial public offering (IPO) was on 01 October 2021

Is Nutriband in the S&P 500?

No, Nutriband is not included in the S&P 500 index

Is Nutriband in the NASDAQ 100?

No, Nutriband is not included in the NASDAQ 100 index

Is Nutriband in the Dow Jones?

No, Nutriband is not included in the Dow Jones index

When was Nutriband's last earnings report?

Nutriband's most recent earnings report was on 3 September 2024

When does Nutriband report earnings?

The next expected earnings date for Nutriband is 13 December 2024

Should I buy Nutriband stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions